Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PLEGRIDY® safely and effectively. See full prescribing information for PLEGRIDY. PLEGRIDY (peginterferon beta-1a) injection, for subcutaneous or intramuscular useInitial U.S. Approval: 2014
Medication labelWhy this: Advisory · dailymed-prescription
PLEGRIDY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
- generic_name
- peginterferon beta-1a
- product_names
- peginterferon beta-1a
- ndc
- 64406-015, 64406-015-02, 64406-015-01, 64406-011, 64406-011-02, 64406-011-01, 64406-017, 64406-017-02, 64406-017-01, 64406-016, 64406-016-01, 64406-014, 64406-014-02, 64406-013, 64406-013-02, 64406-012, 64406-012-01, 64406-010, 64406-010-02, 64406-009, 64406-009-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en